Dear Sir, High blood pressure (BP) is often observed in acute stroke, and especially in intracerebral haemorrhage (ICH) patients on admission to hospital. [1] [2] [3] [4] [5] [6] [7] [8] The underlying pathophysiological mechanism for this rise in BP is not clear and has generally been regarded as a direct and specific reaction to the vascular event itself, or has been associated with different factors such as Cushing response, stress of hospitalisation, autonomic nervous system damage, and history of hypertension. [3] [4] [5] [6] Although these mechanisms may be operant, BP in stroke patients is probably the result of multifactorial interactions between pre-existing factors and specific aspects of the vascular event. Previous studies in patients with ICH 4, 5 were mainly concerned with evaluating relations between BP and certain clinical and radiographic characteristics of the haemorrhage and ignored pre-existing factors that may determine BP. These factors may contribute heavily to the high BP observed at ICH onset, and in such cases the rise in BP may trigger bleeding rather than being an epiphenomenon.
This study examines the relations between BP measured within 24 h of spontaneous ICH onset and a set of factors that may have a role in determining BP. In particular, we tested the hypothesis that elevated BP after ICH is largely determined by certain pre-existing factors, namely hypertensive status and features of previous antihypertensive treatment.
The study group consisted of 809 patients with spontaneous supratentorial ICH. The sample was part of a prospective, observational study that collected acute and follow-up data on patients with ICH admitted to neurological, neurosurgical, and intensive care departments of our university hospital between January 1979 and December 1996. The diagnosis of ICH was based on CT scans in all cases. Patients with primary intraventricular ICH, infratentorial ICH or bleeding related to brain tumours, CNS infections, surgical intervention and venous occlusion were excluded from the study, as were patients with late admission (424 h after onset).
The following baseline characteristics were considered: sex, age, history of hypertension (patients were regarded as: (1) known hypertensive if their BP readings before the stroke had repeatedly exceeded 160/90 mmHg or if they used antihypertensive drugs to treat hypertension only; (2) newly diagnosed hypertensive if patients were discharged with antihypertensive treatment), diabetes mellitus (previous diagnosis of diabetes and/or use of antidiabetic agents or need of antidiabetic treatment on discharge), current smoking, alcohol abuse (more than 400 ml/week pure ethanol), Glasgow Coma Scale (GCS) on admission and features of ICH (location, volume and presence/absence of ventricular or subarachnoid spread, midline shift and early ventricular enlargement). The volume of haematoma (in ml) was calculated using the methods suggested by Kothari et al. Prior antihypertensive medication was categorised by number of drugs (one vs more than one), treatment (once/twice vs more than twice a day), pharmaceutical preparation (short-acting vs slow-release drugs), and by class of antihypertensive agent (diuretics, calcium channel blockers, ACE inhibitors, centrally acting alpha-agonists, and other).
In the vast majority of patients, the first BP reading after onset of ICH was obtained on admission to the emergency department by medical per-sonnel of the department using a mercury sphygmomanometer. In some cases, BP was also measured prior to arrival by family physicians or ambulance doctors or in other referring health centres. In our analysis, we used the first BP reading after ICH onset. The mean arterial blood pressure (MAP) was calculated by adding one third of the differential pressure (systolic minus diastolic) to diastolic pressure. High BP was defined as values exceeding the cutoff point of the fourth quartile in each group of patients (ie whole cohort, normotensive patients, hyper-tensive patients, and treated hypertensive patients).
Stepwise multiple regression analysis was used to find predictors of MAP levels. Univariate and multivariate logistic regression analyses were used to find concomitants of high MAP levels (ie MAP exceeding the 75th percentile). The effects of features of prior antihypertensive treatment and classes of drugs on MAP were evaluated by multivariate logistic regression analysis.
In the whole cohort, stepwise multiple regression analysis with inclusion of all baseline characteristics as covariates identified arterial hypertension as the most powerful predictor of MAP levels (Po0.0001). Other significant predictors were volume of haematoma (P ¼ 0.012) and ventricular spread (P ¼ 0.045). The whole cohort consisted of 273 (33.7%) normotensive and 536 (66.3%) hypertensive patients. In normotensive patients, MAP was directly related to age (Po0.0001) and midline shift (P ¼ 0.0006). In hypertensive patients, lack of prior antihypertensive treatment was the most powerful factor associated with MAP (Po0.0001). In these patients, MAP was also directly associated with volume of a haematoma (P ¼ 0.015) and ventricular spread (P ¼ 0.001) and inversely related to age (Po0.0001).
Factors associated with high BP, ie BP exceeding the fourth MAP quartile, were evaluated in the whole cohort, in normotensive patients, and in hypertensive patients. In the whole cohort, the only independent predictors of high MAP were arterial hypertension, volume of haematoma, and age with an inverse effect. Age, with an inverse effect, and volume of a haematoma continued to be independent predictors of high MAP in hypertensive patients, but in these patients the most powerful predictor was the absence of prior antihypertensive treatment. Among normotensive patients, high BP was only predicted by age with a direct effect, and marginally by midline shift (Table 1) .
Prior to ICH onset, 276 hypertensive patients were taking antihypertensives and 260 were untreated. Of the 276 treated patients, 90 took more than one drug, 102 were treated more than twice a day, and 59 used long-acting drugs. All these features were associated with MAP, and multivariate logistic regression analysis showed that the likelihood of belonging to the fourth MAP quartile was increased by the use of two or more drugs, treatment more than twice a day, and the use of short-acting drugs ( Table 2) .
The percentage of patients with high BP varied widely in relation to the class of drugs used, ranging from 9.2% for patients treated with calcium channel blockers to 47.1% for patients treated with centrally acting alpha-agonists. Preliminary analysis of drug classes showed that the effect of captopril was significantly different from that of other ACE inhibitors, so this drug was evaluated separately. Taking the class of calcium channel blockers as reference, some classes such as ACE inhibitors other than captopril and diuretics were not associated with a significantly greater risk of high BP, unlike captopril, and centrally acting alpha-agonists (Table 2) .
A number of studies have found that many patients had high BP, often very high, soon after ICH. 4, 5 The present results confirm this finding and show that although elevated BP is favoured by certain haematoma characteristics, it depends above all on preexisting factors. These included arterial hypertension and features of prior antihypertensive treatment.
Our separate analyses of the whole cohort, normotensive, and hypertensive patients suggest that predictors of BP are different in the three groups. In the whole cohort, arterial hypertension, age, and volume of haematoma were the only independent predictors of high BP. In normotensive patients, high BP was only predicted by age, and in hypertensive patients by the absence of antihypertensive treatment, age, and volume of haematoma. Volume of haematoma has been found to be a predictor of BP. 5 There is evidence that high BP is associated with a history of arterial hypertension, 5 but some authors failed to find such a relation. 4 An inverse relation between age and BP has been reported by some authors. 5 Our data suggest that aging only had an inverse relation with MAP in hypertensive patients, whereas in normotensive patients the relation was direct. A possible explanation for the inverse relation found in hypertensive patients may be the fact that more younger subjects were untreated than older subjects (57.3 vs 43.3%, P ¼ 0.0024). 
Research letter
Features of prior antihypertensive treatment have never been considered in evaluating factors that may predict BP after ICH. It is evident from our results that the main factor affecting BP in hypertensive patients was the lack of antihypertensive treatment. Among treated hypertensive patients, several aspects of prior antihypertensive treatment seem to be related to BP, in particular the class of drugs used. Compliance of patients may influence the relation between the number of daily doses and BP. However, the fact that more patients treated more than twice a day took captopril or centrally acting alphaagonists than patients treated only once or twice a day (60.4 vs 25.4%, Po0.0001) may explain this finding. It is less easy to explain the association between high BP and the use of more than one drug. Patients with more severe hypertension may be treated with more drugs; however, compliance and the use of certain drugs may again play a role. Indeed, patients in polytherapy were more often treated with captopril or centrally acting alphaagonists than patients who took only one drug (49.5 vs 24.3%, Po0.0001).
In conclusion, our results suggest that many factors conventionally regarded as responsible for high BP after ICH are indeed of relative importance and strongly support the view that elevated BP may be of pathophysiological significance and not simply an epiphenomenon of the stress response to ICH. 
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